Deutsche Bank Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)
Deutsche Bank analyst Falko Friedrichs maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €44.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Friedrichs covers the Healthcare sector, focusing on stocks such as Carl Zeiss Meditec, Fresenius SE & Co. KGaA, and Siemens Healthineers AG. According to TipRanks, Friedrichs has an average return of -2.4% and a 41.37% success rate on recommended stocks.
In addition to Deutsche Bank , Fresenius Medical Care AG & Co. KGaA also received a Hold from Kepler Capital ‘s Oliver Reinberg in a report issued on January 21. However, on January 23, J.P. Morgan maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).
0H9X market cap is currently €10.81B and has a P/E ratio of 15.18.
Read More on GB:0H9X:
Disclaimer & DisclosureReport an Issue
- Fresenius Medical price target lowered to EUR 39.50 from EUR 48.50 at Citi
- Fresenius Medical downgraded to Neutral from Buy at Goldman Sachs
- Fresenius Medical to accelerate its share buyback program
- Fresenius Medical price target raised to $28 from $26 at Truist
- Fresenius Medical price target lowered to EUR 37 from EUR 39 at Morgan Stanley
